Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 4, 2014, Pages 469-478

  Rodger, M A ^a,b,c   Walker, M C ^a,b,c   Smith, G N ^d,e   Wells, P S ^a,b,c   Ramsay, T ^a,c   Langlois, N J ^a   Carson, N ^f   Carrier, M ^a,b,c   Rennicks White, R ^a   Shachkina, S ^g   Wen, S W ^a,b,c  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

^e KINGSTON GENERAL HOSPITAL   (Canada)

^f CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^g HEALTH CANADA   (Canada)

Author keywords

Cohort study; Genetics; Meta analysis; Pregnancy; Risk factors

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; BLOOD CLOTTING FACTOR 5;

ADULT; ARTICLE; BLOOD SAMPLING; CAUCASIAN; COHORT ANALYSIS; DELIVERY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; NULLIPARA; OUTCOME ASSESSMENT; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; SOLUTIO PLACENTAE; STILLBIRTH; TERTIARY CARE CENTER; THROMBOPHILIA; COMPLICATION; GENETICS; HETEROZYGOTE; MUTATION; NEWBORN; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TREATMENT OUTCOME;

ADULT; FACTOR V; FEMALE; HETEROZYGOTE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MUTATION; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA; TREATMENT OUTCOME;

EID: 84898040080     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12509     Document Type: Article

References (19)

1. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342: 374-80.
2. Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 2006; 10: 1-110.
3. Howley HE, Walker M, Rodger MA. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 2005; 192: 694-708.
4. Kovalevsky G, Gracia CR, Berlin JA, Sammel MD, Barnhart KT. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss. A meta-analysis. Arch Intern Med 2004; 164: 558-63.
5. Weiner Z, Younis JS, Blumenfeld Z, Shalev E. Assessment of uterine placental circulation in thrombophilic women. Semin Thromb Hemost 2003; 29: 213-8.
6. Rodger MA, Betancourt MT, Clark P, Lindqvist PG, Dizon-Townson D, Said J, Seligsohn U, Carrier M, Salomon O, Greer IA. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PLoS Med 2010; 7: e1000292.
7. Walker MC, Finkelstein SA, Rennicks WR, Shachkina S, Smith GN, Wen SW, Rodger M. The Ottawa and Kingston (OaK) Birth Cohort: development and achievements. J Obstet Gynaecol Can 2011; 33: 1124-33.
8. Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M, Blondel B, Breart G. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001; 108: E35.
9. Rodeghiero F, Tosetto A. The epidemiology of inherited thrombophilia: the VITA Project. Vicenza Thrombophilia and Atherosclerosis Project. Thromb Haemost 1997; 78: 636-40.
10. Middeldorp S, Levi M. Thrombophilia: an update. Semin Thromb Hemost 2007; 33: 563-72.
11. Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli I, Hague W, Rosene MK, Greer I. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol 2008; 112: 320-4.
12. Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, MacPherson C, van Dorsten JP, Landon M, Miodovnik M, Paul R, Meis P, Thurnau G, Dombrowski M. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol 2002; 186: 422-6.
13. van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006; 195: 723-8.
14. Rodger MA. Anticoagulant prophylaxis for placenta mediated pregnancy complications. Thromb Res 2011; 127(Suppl 3): S76-80.
15. Mello G, Parretti E, Fatini C, Riviello C, Gensini F, Marchionni M, Scarselli GF, Gensini GF, Abbate R. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 2005; 45: 86-91.
16. Rey E, Garneau P, David M, Gauthier R, Leduc L, Michon N, Morin F, Demers C, Kahn SR, Magee LA, Rodger M. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009; 7: 58-64.
17. Gris JC, Chauleur C, Faillie JL, Baer G, Mares P, Fabbro-Peray P, Quere I, Lefrant JY, Haddad B, Dauzat M. Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial. Thromb Haemost 2010; 104: 771-9.
18. Gris JC, Chauleur C, Molinari N, Mares P, Fabbro-Peray P, Quere I, Lefrant JY, Haddad B, Dauzat M. Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial. Thromb Haemost 2011; 106: 1053-61.
19. de Vries JIP, van Pampus MG, Hague WM, Bezemer PD, Joosten JH. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J Thromb Haemost 2012; 10: 64-72.